Actual 10-year survival after resection of colorectal liver metastases defines cure.
about
Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastasesHepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancerPreoperative selection of patients with colorectal cancer liver metastasis for hepatic resectionAdjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysisColorectal cancer: Metastases to a single organOligometastasis and oligo-recurrence: more than a mirageDesigning liver resections and pushing the envelope with resections for hepatic colorectal metastasesStereotactic body radiation therapy for liver metastasesDevelopment of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panelA review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proofMicroRNA expression characterizes oligometastasis(es)Can oncology recapitulate paleontology? Lessons from species extinctionsLocoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal ChemotherapyChemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapyPeri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials.Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Weak stromal Caveolin-1 expression in colorectal liver metastases predicts poor prognosis after hepatectomy for liver-only colorectal metastases.Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?Surgery for colorectal liver metastases.Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapyWhat defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up.Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases.Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastasesSelection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal.Cost-effectiveness of first-line treatments for patients with KRAS wild-type metastatic colorectal cancerSurgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.The prognostic value of liver tumor T cell infiltratesCritical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastasesStereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.Oncologic outcome after cessation or dose reduction of capecitabine in patients with colon cancer.Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinomaNeutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases
P2860
Q26751389-E7910F71-EC47-470A-8B35-96ED745076D0Q26772267-62F6A833-2589-49CC-8D22-2371A4ED87F8Q26774687-BA16B4C1-B256-4013-BF6C-1A50EBF6B002Q26774704-EFD64C8D-6C71-4807-9273-D9A06B5F6858Q26778009-3793ACF7-B57C-4FD0-AEB3-A0AB5566657AQ26828767-B89724EA-6765-479E-BF40-2FE40E8316F0Q26864128-E5F1667C-E0E6-438A-9435-C51C77AF6656Q27008308-86AF97C9-B9B9-4EFE-9B2E-1D69091E1222Q27014926-C63C5D22-C894-46F9-BED8-4998473719DBQ27022812-612FB9B8-57C2-4A69-B3F7-40C4FA19096EQ27311314-9C3DFC93-A052-4972-8BB6-DB91312AA651Q28607703-EF312169-A4EB-408E-BE64-16023B518803Q30415022-E3521978-595B-4449-B9A3-76935151E890Q31031044-589EDB82-9391-46F0-9DFB-D9345B49C604Q33419966-F0F4DB3E-6C9F-4A82-8CAE-60675A11A33BQ33515915-7B7D4149-E0F3-4F40-B974-4DDFDFE6D600Q33558347-7CF3258E-848C-4C78-9918-86682C214DDCQ33611362-6D4B0C82-8E48-4CB3-B91B-5178F67CF2AEQ33679628-F5129A3A-3C48-47AA-A7ED-2913B3C6D2B2Q33700495-187A0B6B-F834-4E7B-8C18-B40FFD4B8E42Q33704416-8AF0A508-D0EA-444D-AA6A-02DFAE314AFAQ33724135-40D6345F-AC26-4466-9574-3B68A02B74EEQ33776697-10280FF2-ABD9-4130-9CA1-547E7AB33F78Q33834452-B3532726-78A7-427E-88FD-864C86F4D7E3Q33850248-54FEB7A7-50F9-45A0-9414-7A6CBF0C2557Q33865014-33FB61B5-FCE1-41D3-B4F6-0FBC3C97E2C1Q33873948-61DF84B3-0616-4BB0-A596-131CA313C1FFQ33879785-32405438-0CC2-440C-9D9A-119C5F04DC5FQ33906344-2B839E28-28E9-4AA2-9863-3FCF5C5C3A22Q33982704-FE03B1B7-4397-475C-B9F6-B190923202AAQ34013522-6D7BD4E4-FBEE-4F6A-A6CE-7A5FE1D47F7AQ34052611-599B3A1A-8F00-4E8D-80C9-7CCDB11BC7A1Q34156811-80990759-D57E-416B-9233-B30DF6483B7CQ34196471-56C354F5-8D59-4FF7-A5EE-646D90F85B5DQ34207776-F6EC6F89-85DC-4923-8E94-96A0EE9BC602Q34294365-65967464-6A4C-4919-98EA-AA70F50D4232Q34330617-613A24BA-BB30-4652-9924-29AE9DD38860Q34385292-CB9F290D-4E5E-4C1A-9EA8-EFD5F056F8FCQ34503734-4E510C24-C5AC-44B8-B368-3B692ADD2BABQ34577127-671EE845-1378-45B1-B527-F01ADB5A5C27
P2860
Actual 10-year survival after resection of colorectal liver metastases defines cure.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@ast
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@en
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@nl
type
label
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@ast
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@en
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@nl
prefLabel
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@ast
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@en
Actual 10-year survival after resection of colorectal liver metastases defines cure.
@nl
P2093
P50
P356
P1476
Actual 10-year survival after resection of colorectal liver metastases defines cure
@en
P2093
James S Tomlinson
Leslie H Blumgart
Michael D'Angelica
Mithat Gonen
Nancy Kemeny
Peter Kornprat
Ronald P DeMatteo
P304
P356
10.1200/JCO.2007.11.0833
P407
P577
2007-10-01T00:00:00Z